Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 819147, 12 pages
http://dx.doi.org/10.1155/2013/819147
Review Article

Towards Polypharmacokinetics: Pharmacokinetics of Multicomponent Drugs and Herbal Medicines Using a Metabolomics Approach

1Key laboratory of Drug Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
2Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, NC 28081, USA

Received 27 December 2012; Accepted 29 January 2013

Academic Editor: Aiping Lu

Copyright © 2013 Ke Lan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Blaylock, “New developments in phytoprevention and treatment of cancer,” The Journal of the American Nutraceutical Association, vol. 2, pp. 19–29, 1999. View at Google Scholar
  2. J. M. Hollander and J. I. Mechanick, “Complementary and alternative medicine and the management of the metabolic syndrome,” Journal of the American Dietetic Association, vol. 108, no. 3, pp. 495–509, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Chan, “Progress in traditional Chinese medicine,” Trends in Pharmacological Sciences, vol. 16, no. 6, pp. 182–187, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. G. W. Plumb, M. T. Garcia-Conesa, P. A. Kroon, M. Rhodes, S. Ridley, and G. Williamson, “Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora,” Journal of the Science of Food and Agriculture, vol. 79, no. 3, pp. 390–392, 1999. View at Publisher · View at Google Scholar
  5. S. M. He, E. Chan, and S. F. Zhou, “ADME properties of herbal medicines in humans: evidence, challenges andstrategies,” Current Pharmaceutical Design, vol. 17, no. 4, pp. 357–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Xie, A. Zhao, L. Zhao et al., “Metabolic fate of tea polyphenols in humans,” Journal of Proteome Research, vol. 11, no. 6, pp. 3449–3457, 2012. View at Publisher · View at Google Scholar
  7. T. Xue and R. Roy, “Studying traditional Chinese medicine,” Science, vol. 300, no. 5620, pp. 740–741, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. E. F. Nassar and R. E. Talaat, “Strategies for dealing with metabolite elucidation in drug discovery and development,” Drug Discovery Today, vol. 9, no. 7, pp. 317–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Pelkonen, A. Tolonen, T. Korjamo, M. Turpeinen, and H. Raunio, “From known knowns to known unknowns: predicting in vivo drug metabolites,” Bioanalysis, vol. 1, no. 2, pp. 393–414, 2009. View at Google Scholar · View at Scopus
  10. A. Tolonen, M. Turpeinen, and O. Pelkonen, “Liquid chromatography-mass spectrometry in in vitro drug metabolite screening,” Drug Discovery Today, vol. 14, no. 3-4, pp. 120–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Lindon, E. Holmes, and J. K. Nicholson, “Metabonomics: systems biology in pharmaceutical research and development,” Current Opinion in Molecular Therapeutics, vol. 6, no. 3, pp. 265–272, 2004. View at Google Scholar · View at Scopus
  12. J. K. Nicholson and J. C. Lindon, “Systems biology: metabonomics,” Nature, vol. 455, no. 7216, pp. 1054–1056, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. K. Nicholson and I. D. Wilson, “Understanding “global” systems biology: metabonomics and the continuum of metabolism,” Nature Reviews Drug Discovery, vol. 2, no. 8, pp. 668–676, 2003. View at Google Scholar · View at Scopus
  14. Y. Wang, H. Tang, J. K. Nicholson, P. J. Hylands, J. Sampson, and E. Holmes, “A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion,” Journal of Agricultural and Food Chemistry, vol. 53, no. 2, pp. 191–196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. W. Sumner, E. Urbanczyk-Wochniak, and C. D. Broeckling, “Metabolomics data analysis, visualization, and integration,” Methods in Molecular Biology, vol. 406, pp. 409–436, 2007. View at Google Scholar · View at Scopus
  16. G. Xie, R. Plumb, M. Su et al., “Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research,” Journal of Separation Science, vol. 31, no. 6-7, pp. 1015–1026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. C. Wu, G. C. Yen, B. S. Wang et al., “Antimutagenic and antimicrobial activities of pu-erh tea,” LWT—Food Science and Technology, vol. 40, no. 3, pp. 506–512, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. B. S. Wang, H. M. Yu, L. W. Chang, W. J. Yen, and P. D. Duh, “Protective effects of pu-erh tea on LDL oxidation and nitric oxide generation in macrophage cells,” LWT—Food Science and Technology, vol. 41, no. 6, pp. 1122–1132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ni, M. Su, J. Lin et al., “Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress,” FEBS Letters, vol. 582, no. 17, pp. 2627–2636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Q. Chen, Y. Ye, H. Cheng, J. F. Yin, and C. Sun, “Comparative analysis of theanine, caffein and polyphenolic constituents in green tea, black tea and puer tea,” Food Research and Development, vol. 28, no. 12, pp. 141–144, 2007. View at Google Scholar
  21. K. Lan and W. Jia, “An Integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation,” Current Drug Metabolism, vol. 11, no. 1, pp. 105–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Wei, X. Shi, S. Kim et al., “Data preprocessing method for liquid chromatography-mass spectrometry based metabolomics,” Analytical Chemistry, vol. 84, no. 18, pp. 7963–7971, 2012. View at Publisher · View at Google Scholar
  23. J. Trygg, E. Holmes, and T. Lundstedt, “Chemometrics in metabonomics,” Journal of Proteome Research, vol. 6, no. 2, pp. 469–479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Ma and S. K. Chowdhury, “Analytical strategies for assessment of human metabolites in preclinical safety testing,” Analytical Chemistry, vol. 83, no. 13, pp. 5028–5036, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Wang, S. Wang, Y. Liu, L. Yan, G. Dou, and Y. Gao, “Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism of aconitine,” Journal of Chromatography B, vol. 844, no. 2, pp. 292–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. F. Zhao, F. R. Song, X. H. Guo, and S. Y. Liu, “Studies on the biotransformation of aconitine in human intestinal bacteria using soft-ionization mass spectrometry,” Chemical Journal of Chinese Universities, vol. 29, no. 1, pp. 55–59, 2008. View at Google Scholar · View at Scopus
  27. L. Tang, L. Ye, C. Lv, Z. Zheng, Y. Gong, and Z. Liu, “Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes,” Toxicology Letters, vol. 202, no. 1, pp. 47–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Wang, Z. Pi, W. Liu, Y. Zhao, and S. Liu, “Effect of pH on the metabolism of aconitine under rat intestinal bacteria and analysis of metabolites using HPLC/MS-MSn technique,” Chinese Journal of Chemistry, vol. 28, no. 12, pp. 2494–2500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. S. Plumb, C. L. Stumpf, J. H. Granger, J. Castro-Perez, J. N. Haselden, and G. J. Dear, “Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids,” Rapid Communications in Mass Spectrometry, vol. 17, no. 23, pp. 2632–2638, 2003. View at Google Scholar · View at Scopus
  30. H. Idborg, P. O. Edlund, and S. P. Jacobsson, “Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data,” Rapid Communications in Mass Spectrometry, vol. 18, no. 9, pp. 944–954, 2004. View at Google Scholar · View at Scopus
  31. C. Chen, F. J. Gonzalez, and J. R. Idle, “LC-MS-based metabolomics in drug metabolism,” Drug Metabolism Reviews, vol. 39, no. 2-3, pp. 581–597, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. D. Patterson, F. J. Gonzalez, and J. R. Idle, “Xenobiotic metabolism: a view through the metabolometer,” Chemical Research in Toxicology, vol. 23, no. 5, pp. 851–860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. H. Johnson, A. D. Patterson, J. R. Idle, and F. J. Gonzalez, “Xenobiotic metabolomics: major impact on the metabolome,” Annual Review of Pharmacology and Toxicology, vol. 52, pp. 37–56, 2012. View at Publisher · View at Google Scholar
  34. C. Chen, L. Meng, X. Ma et al., “Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone),” Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 3, pp. 1330–1342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Giri, J. R. Idle, C. Chen, T. M. Zabriskie, K. W. Krausz, and F. J. Gonzalez, “A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse,” Chemical Research in Toxicology, vol. 19, no. 6, pp. 818–827, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Chen, X. Ma, M. A. Malfatti et al., “A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach,” Chemical Research in Toxicology, vol. 20, no. 3, pp. 531–542, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Giri, K. W. Krausz, J. R. Idle, and F. J. Gonzalez, “The metabolomics of (±)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases,” Biochemical Pharmacology, vol. 73, no. 4, pp. 561–573, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Fardet, R. Llorach, A. Orsoni et al., “Metabolomics provide new insight on the metabolism of dietary phytochemicals in rats,” Journal of Nutrition, vol. 138, no. 7, pp. 1282–1287, 2008. View at Google Scholar · View at Scopus
  39. C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez, “Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice,” Journal of Biological Chemistry, vol. 283, no. 8, pp. 4543–4559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Cheng, X. Ma, K. W. Krausz, J. R. Idle, and F. J. Gonzalez, “Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity,” Drug Metabolism and Disposition, vol. 37, no. 8, pp. 1611–1621, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Sun, L. K. Schnackenberg, and R. D. Beger, “Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics,” Drug Metabolism Letters, vol. 3, no. 3, pp. 130–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Li, J. Lu, and X. Ma, “Profiling the reactive metabolites of xenobiotics using metabolomic technologies,” Chemical Research in Toxicology, vol. 24, no. 5, pp. 744–751, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. U. Lutz, N. Bittner, R. W. Lutz, and W. K. Lutz, “Metabolite profiling in human urine by LC-MS/MS: method optimization and application for glucuronides from dextromethorphan metabolism,” Journal of Chromatography B, vol. 871, no. 2, pp. 349–356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Ma, C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez, “A metabolomic perspective of melatonin metabolism in the mouse,” Endocrinology, vol. 149, no. 4, pp. 1869–1879, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Niu, F. Li, D. X. Tan et al., “Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice,” Journal of Pineal Research, vol. 49, no. 2, pp. 106–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Y. Cho, D. W. Kang, X. Ma et al., “Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation,” Journal of Lipid Research, vol. 50, no. 5, pp. 924–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Liu, Y. Chen, Z. Yang et al., “New metabolites of fenofibrate in SpragueDawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS,” Xenobiotica, vol. 39, no. 4, pp. 345–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Liu, A. D. Patterson, Z. Yang et al., “Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics,” Drug Metabolism and Disposition, vol. 37, no. 6, pp. 1157–1163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Sun, L. S. Von Tungeln, W. Hines, and R. D. Beger, “Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis,” Journal of Chromatography B, vol. 877, no. 24, pp. 2557–2565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Li, A. D. Patterson, C. C. Höfer, K. W. Krausz, F. J. Gonzalez, and J. R. Idle, “Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics,” Biochemical Pharmacology, vol. 80, no. 7, pp. 1063–1074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Li, L. Wang, G. L. Guo, and X. Ma, “Metabolism-mediated drug interactions associated with ritonavir-boosted tipranavir in mice,” Drug Metabolism and Disposition, vol. 38, no. 5, pp. 871–878, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. R. P. Schneider, H. Zhang, L. Mu, A. S. Kalgutkar, and R. Bonner, “Utility of multivariate analysis in support of in vitro metabolite identification studies: retrospective analysis using the antidepressant drug nefazodone,” Xenobiotica, vol. 40, no. 4, pp. 262–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Sun, L. K. Schnackenberg, D. K. Hansen, and R. D. Beger, “Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics,” Bioanalysis, vol. 2, no. 2, pp. 207–216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Li and X. Ma, “Metabolomic screening and identification of the bioactivation pathways of ritonavir,” Chemical Research in Toxicology, vol. 24, no. 12, pp. 2109–2114, 2011. View at Publisher · View at Google Scholar
  55. F. Li, A. D. Patterson, C. C. Höfer, K. W. Krausz, F. J. Gonzalez, and J. R. Idle, “A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics,” Biochemical Pharmacology, vol. 81, no. 8, pp. 1043–1053, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Tan, Z. Lou, X. Dong, W. Li, and Y. Chai, “Urinary metabolites of isoliquiritigenin in wistar rats using UHPLC–TOF–MS-based xenometabolomics,” Chromatographia, vol. 74, no. 3-4, pp. 341–348, 2011. View at Publisher · View at Google Scholar
  57. X. Shi, D. Yao, and C. Chen, “Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis,” Journal of Biological Chemistry, vol. 287, no. 9, pp. 6336–6349, 2012. View at Publisher · View at Google Scholar
  58. F. Li, A. D. Patterson, K. W. Krausz et al., “Metabolomics reveals the metabolic map of procainamide in humans and mice,” Biochemical Pharmacology, vol. 83, no. 10, pp. 1435–1444, 2012. View at Publisher · View at Google Scholar
  59. Y. Zhen, O. Slanař, K. W. Krausz et al., “3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio,” Drug Metabolism and Disposition, vol. 34, no. 9, pp. 1563–1574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Llorach-Asunción, O. Jauregui, M. Urpi-Sarda, and C. Andres-Lacueva, “Methodological aspects for metabolome visualization and characterization. A metabolomic evaluation of the 24 h evolution of human urine after cocoa powder consumption,” Journal of Pharmaceutical and Biomedical Analysis, vol. 51, no. 2, pp. 373–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Llorach, I. Garrido, M. Monagas et al., “Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols,” Journal of Proteome Research, vol. 9, no. 11, pp. 5859–5867, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Xie, M. Ye, Y. Wang et al., “Characterization of pu-erh tea using chemical and metabolic profiling approaches,” Journal of Agricultural and Food Chemistry, vol. 57, no. 8, pp. 3046–3054, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. E. J. J. van Velzen, J. A. Westerhuis, J. P. M. van Duynhoven et al., “Multilevel data analysis of a crossover designed human nutritional intervention study,” Journal of Proteome Research, vol. 7, no. 10, pp. 4483–4491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. E. J. J. van Velzen, J. A. Westerhuis, J. P. M. van Duynhoven et al., “Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites,” Journal of Proteome Research, vol. 8, no. 7, pp. 3317–3330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. F. P. J. Martin, S. Rezzi, E. Peré-Trepat et al., “Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects,” Journal of Proteome Research, vol. 8, no. 12, pp. 5568–5579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. V. Croixmarie, T. Umbdenstock, O. Cloarec et al., “Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/mass spectrometry metabonomic profiles using human hepatocyte cultures,” Analytical Chemistry, vol. 81, no. 15, pp. 6061–6069, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Li, M. Zhou, A. Zhao, and W. Jia, “Traditional Chinese medicine: balancing the gut ecosystem,” Phytotherapy Research, vol. 23, no. 9, pp. 1332–1335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Li, E.-H. Liu, and X.-D. Wen, “Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models,” TrAC—Trends in Analytical Chemistry, vol. 27, no. 1, pp. 66–77, 2008. View at Publisher · View at Google Scholar
  69. G.-Z. Xin, L.-W. Qi, Z.-Q. Shi, G.-J. Wang, and J. Shang, “Strategies for integral metabolism profile of multiple compounds in herbal medicines: pharmacokinetics, metabolites characterization and metabolic interactions,” Current Drug Metabolism, vol. 12, no. 9, pp. 809–817, 2011. View at Google Scholar
  70. C. Y. Li, L. W. Qi, and P. Li, “Correlative analysis of metabolite profiling of Danggui Buxue Tang in rat biological fluids by rapid resolution LC-TOF/MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 1, pp. 146–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Xiang, X. Qiao, Q. Wang, D. Guo, and M. Ye, “From single compounds to herbal extract: a strategy to systematically characterize the metabolites of licorice in rats,” Drug Metabolism and Disposition, vol. 39, no. 9, pp. 1597–1608, 2011. View at Publisher · View at Google Scholar
  72. X. Qiao, M. Ye, C. Xiang, Q. Wang, W.-J. Miao, and D.-A. Guo, “Analytical strategy to reveal the in vivo process of multi-component herbal medicine: a pharmacokinetic study of licorice using liquid chromatography coupled with triple quadrupole mass spectrometry,” Journal of Chromatography A, vol. 1258, pp. 84–93, 2012. View at Publisher · View at Google Scholar
  73. P. Gong, N. Cui, L. Wu et al., “Chemicalome and metabolome matching approach to elucidating biological metabolic networks of complex mixtures,” Analytical Chemistry, vol. 84, no. 6, pp. 2995–3002, 2012. View at Publisher · View at Google Scholar
  74. A. K. Smilde, J. A. Westerhuis, H. C. J. Hoefsloot et al., “Dynamic metabolomic data analysis: a tutorial review,” Metabolomics, vol. 6, no. 1, pp. 3–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. J. A. Westerhuis, E. J. J. van Velzen, H. C. J. Hoefsloot, and A. K. Smilde, “Multivariate paired data analysis: multilevel PLSDA versus OPLSDA,” Metabolomics, vol. 6, no. 1, pp. 119–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. J. van Duynhoven, E. E. Vaughan, D. M. Jacob et al., “Metabolic fate of polyphenols in the human superorganism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, supplement 1, pp. 4531–4538, 2011. View at Publisher · View at Google Scholar
  77. J. P. M. van Duynhoven, E. J. J. van Velzena, and J. A. Westerhuis, “Nutrikinetics: concept, technologies, applications, perspectives,” Trends in Food Science and Technology, vol. 26, no. 1, pp. 4–13, 2012. View at Publisher · View at Google Scholar
  78. R. Llorach, M. Garcia-Aloy, S. Tulipani, and C. Andres-Lacueva, “Nutrimetabolomic strategies to develop new biomarkers of intake and health effects,” Journal of Agricultural and Food Chemistry, vol. 60, no. 36, pp. 8797–8808, 2012. View at Publisher · View at Google Scholar
  79. E. M. Lenz and I. D. Wilson, “Analytical strategies in metabonomics,” Journal of Proteome Research, vol. 6, no. 2, pp. 443–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. J. van der Greef, “Perspective: all systems go,” Nature, vol. 480, no. 7378, p. S87, 2011. View at Publisher · View at Google Scholar
  81. T. Ideker, T. Galitski, and L. Hood, “A new approach to decoding life: systems biology,” Annual Review of Genomics and Human Genetics, vol. 2, pp. 343–372, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. H. Kitano, “Systems biology: a brief overview,” Science, vol. 295, no. 5560, pp. 1662–1664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Lan, Y. Zhang, J. Yang, and L. Xu, “Simple quality assessment approach for herbal extracts using high performance liquid chromatography-UV based metabolomics platform,” Journal of Chromatography A, vol. 1217, no. 8, pp. 1414–1418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. Z. Wang, H. Hu, F. Chen et al., “Metabolic profiling assisted quality assessment of Rhodiola rosea extracts by high-performance liquid chromatography,” Planta Medica, vol. 78, no. 7, pp. 740–746, 2012. View at Publisher · View at Google Scholar
  85. L.-X. Duan, M. Li, M. Chen et al., “Use of the metabolomics approach to characterize chinese medicinal material Huangqi,” Molecular Plant, vol. 5, no. 2, pp. 376–386, 2012. View at Publisher · View at Google Scholar
  86. M. Wang, R. J. A. N. Lamers, H. A. A. J. Korthout et al., “Metabolomics in the context of systems biology: Bridging Traditional Chinese Medicine and molecular pharmacology,” Phytotherapy Research, vol. 19, no. 3, pp. 173–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Zhang, H. Sun, Z. Wang, W. Sun, P. Wang, and X. Wang, “Metabolomics: towards understanding traditional Chinese medicine,” Planta Medica, vol. 76, no. 17, pp. 2026–2035, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. X. Wang, H. Sun, A. Zhang, W. Sun, P. Wang, and Z. Wang, “Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 5, pp. 859–868, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. P. Liu, S. Liu, D. Tian, and P. Wang, “The applications and obstacles of metabonomics in traditional Chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 945824, 4 pages, 2012. View at Publisher · View at Google Scholar
  90. T. Wu, M. Yang, H.-F. Wei, S.-H. He, S.-C. Wang, and G. Ji, “Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 968083, 11 pages, 2012. View at Publisher · View at Google Scholar
  91. M. Jové, J. C. E. Serrano, N. Ortega et al., “Multicompartmental LC-Q-TOF-based metabonomics as an exploratory tool to identify novel pathways affected by polyphenol-rich diets in mice,” Journal of Proteome Research, vol. 10, no. 8, pp. 3501–3512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. P. J. Turnbaugh, R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon, “The Human Microbiome Project,” Nature, vol. 449, no. 7164, pp. 804–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Qin, R. Li, J. Raes et al., “A human gut microbial gene catalogue established by metagenomic sequencing,” Nature, vol. 464, no. 7285, pp. 59–65, 2010. View at Google Scholar
  94. M. Arumugam, J. Raes, E. Pelletier et al., “Enterotypes of the human gut microbiome,” Nature, vol. 473, no. 7346, pp. 174–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. T. H. M. P. Consortium, “A framework for human microbiome research,” Nature, vol. 486, no. 7402, pp. 215–221, 2012. View at Google Scholar
  96. T. H. M. P. Consortium, “Structure, function and diversity of the healthy human microbiome,” Nature, vol. 486, no. 7402, pp. 207–214, 2012. View at Google Scholar
  97. I. Rosabelle McManus, A. O. Contag, and R. E. Olson, “Characterization of endogenous ethanol in the mammal,” Science, vol. 131, no. 3393, pp. 102–103, 1960. View at Google Scholar · View at Scopus
  98. G. Spinucci, M. Guidetti, E. Lanzoni, and L. Pironi, “Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth,” European Journal of Gastroenterology and Hepatology, vol. 18, no. 7, pp. 799–802, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Compare, P. Coccoli, A. Rocco, O. M. Nardone, S. De Maria, and G. Nardone, “Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 22, no. 6, pp. 471–476, 2012. View at Publisher · View at Google Scholar
  100. F. P. J. Martin, M. E. Dumas, Y. Wang et al., “A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model,” Molecular Systems Biology, vol. 3, article 112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. F. P. J. Martin, Y. Wang, N. Sprenger et al., “Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model,” Molecular Systems Biology, vol. 4, article 157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. F. P. J. Martin, N. Sprenger, I. K. S. Yap et al., “Panorganismal gut microbiome-host metabolic crosstalk,” Journal of Proteome Research, vol. 8, no. 4, pp. 2090–2105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. F. P. J. Martin, Y. Wang, I. K. S. Yap et al., “Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity,” Journal of Proteome Research, vol. 8, no. 7, pp. 3464–3474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. X. Zheng, G. Xie, A. Zhao et al., “The footprints of gut microbial-mammalian co-metabolism,” Journal of Proteome Research, vol. 10, no. 12, pp. 5512–5522, 2011. View at Publisher · View at Google Scholar
  105. J. K. Nicholson, E. Holmes, R. Burcelin, and S. Pettersson, “Host-gut microbiota metabolic interactions,” Science, vol. 336, no. 6086, pp. 1262–1267, 2012. View at Publisher · View at Google Scholar
  106. I. D. Wilson and J. K. Nicholson, “The role of gut microbiota in drug response,” Current Pharmaceutical Design, vol. 15, no. 13, pp. 1519–1523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. T. A. Clayton, D. Baker, J. C. Lindon, J. R. Everett, and J. K. Nicholson, “Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14728–14733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. W. Meinl, S. Sczesny, R. Brigelius-Flohé, M. Blaut, and H. Glatt, “Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat,” Drug Metabolism and Disposition, vol. 37, no. 6, pp. 1179–1186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. B. Björkholm, C. M. Bok, A. Lundin, J. Rafter, M. L. Hibberd, and S. Pettersson, “Intestinal microbiota regulate xenobiotic metabolism in the liver,” PLoS ONE, vol. 4, no. 9, Article ID e6958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Peters, H. G. Janssen, and G. Vivó-Truyols, “Trend analysis of time-series data: a novel method for untargeted metabolite discovery,” Analytica Chimica Acta, vol. 663, no. 1, pp. 98–104, 2010. View at Publisher · View at Google Scholar · View at Scopus